Skip to main content
Journal ArticleOPEN ACCESS

EpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study

  • MOHAMED S. NEGM, M.D. R
  • I. AMER, M.D. S
The Medical Journal of Cairo University (2022) 90(3) 113-119
DOI: 10.21608/mjcu.2022.234835
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Background: Ovarian epithelial cancer is a dreadful gynecologic malignancy, with a usual late diagnosis and humble therapy response. EpCAM over-expression in epithelial ovarian cancer could be considered as a hopeful cancer target therapy.

Cite

CITATION STYLE

APA

MOHAMED S. NEGM, M.D., R. R. M., M. D. ;, & I. AMER, M.D., S. (2022). EpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study. The Medical Journal of Cairo University, 90(3), 113–119. https://doi.org/10.21608/mjcu.2022.234835

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free